Q3 2024 Nautilus Biotechnology Inc Earnings Call Transcript
Key Points
- Nautilus Biotechnology Inc (NAUT) has made significant progress in developing its proteomics platform, particularly in detecting proteoforms, which could have substantial implications for biomarker discovery and drug development.
- The company has demonstrated a scalable and reliable process for building flow cells and chips, and robust single molecule deposition, which are crucial for their platform's success.
- Nautilus Biotechnology Inc (NAUT) has successfully integrated all aspects of their assay and platform, indicating readiness for commercial availability in the near future.
- The company has managed its resources efficiently, maintaining a flat headcount while significantly increasing experimental capacity and output.
- Nautilus Biotechnology Inc (NAUT) has a strong cash position with $221.2 million in cash, cash equivalents, and investments, extending their cash runway into 2027.
- Nautilus Biotechnology Inc (NAUT) is behind on its internal milestones for broad scale discovery, specifically in quantifying a significant number of proteins from complex samples.
- The fallout rate for probe candidates is currently too high, indicating challenges in transitioning probe candidates to platform-ready probes.
- The company has not yet achieved its goal of decoding 500 to 2000 proteins from cell lysate, a critical milestone for their broad scale platform.
- There is uncertainty regarding the exact timeline for achieving key development milestones, such as the broad scale milestone by the US HUPO conference.
- Nautilus Biotechnology Inc (NAUT) faces potential challenges in breaking into the market with established players like Astral and Ultra 2, which have gained traction in the proteomics space.
Good day, everyone. And thank you for standing by and welcome to nautilus' a third quarter, 2024 earnings conference call. At this time. All participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session to participate. You will need to press star 11 on your telephone. You will then hear a message advising your hand is raised to withdraw your question. Simply press star 11 again.
Please be advised that today's conference is being recorded. Now we'll pass the call over to Eyoni with investor relations. Please go ahead.
Thank you.
Earlier today, Nautilus released financial results for the quarter ended, September 30 2024.
If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an email to investor relations at Nautilus dot bio.
Joining me today from Nautilus are Sujal Patel cofounder and CEO Praag Malik, cofounder and chief scientist and Anna Maori,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
